Skip to main content
. 2022 May 4;9:875327. doi: 10.3389/fcvm.2022.875327

FIGURE 11.

FIGURE 11

Forest plot displaying the effects of SGLT2 inhibitors vs. placebo for adverse events in HFpEF patients.